Publications, press articles, rankings, awards
Unified Patent Court and Italy sign headquarters agreement
The Italy and the Unified Patent Court (UPC) have signed a headquarters agreement, see press release of the Italian government.
Pharma and Biotech Patent Litigation: Is the UPC changing litigation strategies?
The Pharma and Biotech Patent Litigation Europe summit which has taken place in Amsterdam was a good opportunity to get an overview from the EPO of the state of play.
IP5 Statistics Report 2022
Recently, the annual IP5 Statistics Report of the world’s five largest IP offices (IP5) was issued.
Review of French and EU case law relating to pharmaceutical trademarks and designs 2023
Lavoix presents a review of pharmaceutical trademark and design decisions handed down by French and European Union courts.
Form informing applicants about entry of PCT in EP phase discontinued
The EPO has announced that the notice from the EPO informing about the entry into the European phase before the EPO is discontinued.
New edition of the IP Barometer
Created more than 10 years ago to gain a better understanding of developments in intellectual property, the IP Barometer also enables us to develop our services to better meet our clients’ expectations in terms of protecting and enhancing the value of their intangible assets.